| Jacob Obholz, DO | |
|
1010 4th St Sw Ste 305, Mason City, IA 50401-2856 | |
| (641) 428-5700 | |
| (641) 428-2515 |
| Full Name | Jacob Obholz |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 1010 4th St Sw Ste 305, Mason City, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689298473 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | R-11930 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jacob Obholz, DO 1000 4th St Sw, Mason City, IA 50401-2800 Ph: (641) 428-5700 | Jacob Obholz, DO 1010 4th St Sw Ste 305, Mason City, IA 50401-2856 Ph: (641) 428-5700 |
News Archive
Researchers duo Emma Derbyshire and Joanne Delange from the Nutritional Insight, Surrey, United Kingdom, explore the role of immunonutrition – nutrition that boosts or influences the immune system for those over 65 years of age in COVID-19. Their study titled, "COVID-19: is there a role for immunonutrition, particularly in the over 65s?," was released in the latest issue of the BMJ Nutrition, Prevention and Health.
Adaptimmune Therapeutics plc, a leader in the use of TCR engineered T-cell therapy to treat cancer, today announced that it has initiated a Phase I/II study of its affinity enhanced T-cell therapy targeting the MAGE-A10 cancer antigen in patients with locally advanced or metastatic (Stage IIIb or IV) non-small cell lung cancer (NSCLC), the most prevalent type of lung cancer representing approximately 85 percent of lung cancers.
Researchers at Nationwide Children's Hospital and Johns Hopkins University have discovered that delivering a small molecule that is highly expressed in normal tissues but lost in diseased cells can result in tumor suppression.
HemaCare Corporation today announced an agreement with Dendreon Corporation to provide cellular collection services in Los Angeles and Maine for their new autologous cellular immunotherapy, PROVENGE® (sipuleucel-T). This personalized medicine is Dendreon's lead product and is the first autologous cellular immunotherapy specifically designed to engage patients' own immune systems to treat cancer.
› Verified 7 days ago
Burt Humburg, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 641-428-7000 Fax: 641-428-6383 | |
Sumathy Nagraj Iyengar, M.D., Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 4th St Sw, Mercy Medical Center-hospitalist Dept, Mason City, IA 50401 Phone: 641-428-7000 | |
Mark C Johnson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 910 N Eisenhower Ave, Mason City, IA 50401 Phone: 641-428-7799 Fax: 641-428-5274 | |
Dr. Joseph Dean Mccracken, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 641-428-6300 Fax: 641-428-6347 | |
Nathaniel Hitt, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 621 S Illinois Ave Ste 100, Mason City, IA 50401 Phone: 641-428-6900 Fax: 641-428-3909 | |
Dr. Byron T Beasley, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-494-5300 Fax: 641-494-5329 | |
Radu Hagau, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-494-5300 Fax: 641-494-5321 |